# Chengdu King's Soft Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/chengdu-king-s-soft-co

- Industry: Software
- Headquarters: Chengdu, China
- Website: http://qingzhi.net/
- Latest round: Series A (May 9, 2022)
- Investors on record: 1

## About

Established in 2016 and based in Chengdu, China, Chengdu King's Soft Co., Ltd. is a company focused on the business of providing adaptation software for laboratories. The company has 15 years of technical precipitation and service experience in laboratory and quality information technology, and the core staff has more than ten years of software development experience. The company's "Qingzhi" series software has covered all 31 provincial administrative divisions in China except Hong Kong, Macao and Taiwan, with more than 800 customers, and has won many honors such as the 2018 Outstanding Contribution Award of Intelligent Food and Drug, and the 2020 Most Competitive Software Enterprise in Sichuan Province. 

The company mainly develops LIMS and other laboratory software under the brand name of King's, and the product line includes: King'sAPS, King'sAuto, King'sAI, etc. The specific products include: LIMS main system, which provides special versions for different testing industries; special OA, which is a special OA system for testing industry and supports the process interaction between LIMS and OA; special CRM, other optional components including mobile LIMS, online business integration components, etc., external portals and interfaces and resource libraries. The company's software covers more than 20 industries, including: comprehensive quality inspection, food, biopharmaceutical, metrology and calibration, environmental protection, machinery manufacturing, electronics and electrical appliances, building materials and construction, etc.

The company raised a series A+ funding in May 2022, this round of financing will be used to continue to deepen the laboratory software business such as LIMS, and at the same time, the company will spin off the automation division and set up a wholly-owned company "Qingsoft Intelligent Control" to accelerate the layout in the field of laboratory automation, especially in new drug development, gene sequencing, clinical diagnosis and other biomedical and life science applications.

## Funding rounds

- Series A, May 9, 2022 — GL Ventures

## Investors

- GL Ventures (https://capitalatlas.ai/funds/gl-ventures) — Series A